Cancer Treatment And Research Communications impact factor, indexing, ranking (2024)

---

Aim and Scope

The Cancer Treatment And Research Communications is a research journal that publishes research related to Biochemistry, Genetics and Molecular Biology; Medicine. This journal is published by the Elsevier Ltd.. The ISSN of this journal is 24682942. Based on the Scopus data, the SCImago Journal Rank (SJR) of cancer treatment and research communications is 0.674.

Also, please check the following important details about cancer treatment and research communications: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Cancer Treatment And Research Communications Ranking

The SJR (SCImago Journal Rank) measures citations weighted by prestige. It is useful for comparing journals within the same field, and forms the basis of the subject category ranking. A journal SJR indicator is a numeric value representing the average number of weighted citations received during a selected year per document published in that journal during the previous three years, as indexed by Scopus. Higher SJR indicator values are meant to indicate greater journal prestige. SJR is developed by the Scimago Lab, originated from a research group at University of Granada. Q1 journals are cited more often and by more prestigious journals than those in the other quartiles.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

CiteScore of an academic journal is a measure reflecting the yearly average number of citations to recent articles published in that journal. This journal evaluation metric was launched in December 2016 by Elsevier as an alternative to the generally used JCR impact factors (calculated by Clarivate). CiteScore is based on the citations recorded in the Scopus database rather than in JCR, and those citations are collected for articles published in the preceding four years instead of two or five.

Source Normalized Impact per Paper (SNIP) is calculated annually from Scopus data. It is a sophisticated metric that intrinsically accounts for field-specific differences in citation practices.

Important Metrics

Journal Title:	Cancer Treatment and Research Communications
Publisher:	Elsevier Ltd.
ISSN:	24682942
Type:	journal
Journal Scope:	Biochemistry, Genetics and Molecular Biology; Medicine
Country:	United Kingdom
H-Index:	18
SJR:	0.674
Quartile:	Cancer Research (Q3); Oncology (Q3)

Indexing

The cancer treatment and research communications is indexed in:

• UGC CARE
• Scopus
• DOAJ
• PubMed

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Quartile

The latest Quartile of cancer treatment and research communications is Q3.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

Publication fee

According to journal website, the publication fee of cancer treatment and research communications is around 2050 USD.

The cancer treatment and research communications has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.

Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the cancer treatment and research communications publishes research articles in 17 weeks on an average.

Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Cancer Treatment And Research Communications?

If your research is related to Biochemistry, Genetics and Molecular Biology; Medicine, then visit the official website of cancer treatment and research communications and send your manuscript.

Tips for publishing in Cancer Treatment And Research Communications:

• Selection of research problem.
• Presenting a solution.
• Designing the paper.
• Make your manuscript publication worthy.
• Write an effective results section.
• Mind your references.

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

Sources: https://www.journals.elsevier.com/cancer-treatment-and-research-communications

---